Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome

Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome

This study contributes to a greater understanding of the utility of molecular biomarkers to identify clinical phenotypes of fragile X syndrome (FXS). Correlations of baseline clinical trial data (molecular measures—<i>FMR1</i> mRNA, <i>CYFIP1</i> mRNA, MMP9 and FMRP protein e...

Full description

Bibliographic Details
Main Authors: Ramkumar Aishworiya, Mei-Hung Chi, Marwa Zafarullah, Guadalupe Mendoza, Matthew Dominic Ponzini, Kyoungmi Kim, Hazel Maridith Barlahan Biag, Angela John Thurman, Leonard Abbeduto, David Hessl, Jamie Leah Randol, Francois V. Bolduc, Sebastien Jacquemont, Sarah Lippé, Paul Hagerman, Randi Hagerman, Andrea Schneider, Flora Tassone
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cells
Subjects:
fragile X syndrome
<i>FMR1</i> mRNA
MMP9
FMRP
clinical trial
outcome measures
Online Access:https://www.mdpi.com/2073-4409/12/14/1920

Similar Items

Similar Items